Melissa Branham-O'Connor, Ph.D. - Publications

Affiliations: 
2009 Biological Sciences Clemson University, Clemson, SC, United States 
Area:
Microbiology Biology, Cell Biology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Branham-O'Connor M, Robichaux WG, Zhang XK, Cho H, Kehrl JH, Lanier SM, Blumer JB. Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3). The Journal of Biological Chemistry. 289: 10738-47. PMID 24573680 DOI: 10.1074/Jbc.M113.515031  0.322
2014 Bradley A, Zheng H, Ziebarth A, Sakati W, Branham-O'Connor M, Blumer JB, Liu Y, Kistner-Griffin E, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Landen CN, Eblen ST. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 35: 1100-9. PMID 24379240 DOI: 10.1093/Carcin/Bgt489  0.388
2010 Branham-O'Connor M, Li J, Kotturi HS, Yu X, Wagner TE, Wei Y. Fusion induced reversal of dendritic cell maturation: an altered expression of inflammatory chemokine and chemokine receptors in dendritomas. Oncology Reports. 23: 545-50. PMID 20043120 DOI: 10.3892/Or_00000668  0.519
2010 Kotturi HS, Li J, Branham-O'Connor M, Yu X, Wagner TE, Wei Y. In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors. Cancer Gene Therapy. 17: 164-70. PMID 19816522 DOI: 10.1038/Cgt.2009.69  0.573
2008 Kotturi HS, Li J, Branham-O'Connor M, Stickel SL, Yu X, Wagner TE, Wei Y. Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation. Gene Therapy. 15: 1302-10. PMID 18463688 DOI: 10.1038/Gt.2008.77  0.581
Show low-probability matches.